{"id":"89zr-cd147","phase":"phase_1","safety":{"commonSideEffects":[{"rate":"20%","effect":"Fatigue"},{"rate":"15%","effect":"Nausea"},{"rate":"10%","effect":"Vomiting"}]},"status":"active","trials":["NCT04841421"],"aliases":[],"patents":[],"pricing":[],"timeline":[],"aiSummary":"Targeting CD147 Used for Non-small cell lung cancer, Breast cancer.","brandName":"89Zr-CD147","companyId":"sinotau-pharmaceutical-group","mechanism":{"_ai_source":"groq-llama-8b","explanation":"CD147 is a transmembrane glycoprotein involved in tumor cell proliferation, invasion, and metastasis. Targeting CD147 has been shown to inhibit tumor growth and angiogenesis.","oneSentence":"Targeting CD147","_ai_confidence":"medium"},"commercial":null,"companyName":"Sinotau Pharmaceutical Group","competitors":[],"genericName":"89Zr-CD147","indications":{"approved":[{"name":"Non-small cell lung cancer"},{"name":"Breast cancer"}]},"labelChanges":[],"trialDetails":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"rwe":[],"genericFilers":[],"relatedDrugs":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}